Warren Averett Asset Management, LLC Viking Therapeutics, Inc. Transaction History
Warren Averett Asset Management, LLC
- $6.36 Billion
- Q4 2024
A detailed history of Warren Averett Asset Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 48,369 shares of VKTX stock, worth $1.65 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
48,369
Previous 35,943
34.57%
Holding current value
$1.65 Million
Previous $2.28 Million
14.46%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding VKTX
# of Institutions
466Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$205 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$168 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$88.4 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$73.5 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.61B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...